CHP
GEVA

Cable Hill Partners’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Cable Hill Partners’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-67
Closed -$7K – 763
2015
Q1 		$7K Buy
+67
New +$7.09K 0.01% 520

Cable Hill Partners's GEVA Position: Q2 2015 in Review

Cable Hill Partners sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 67 shares — an estimated $7K sold.

Cable Hill Partners first reported a position in GEVA in Q1 2015 and held it in 1 quarter. The position peaked at $7K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Cable Hill Partners reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Cable Hill Partners sold 67 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $7K.
  • Cable Hill Partners first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Cable Hill Partners's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $7K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Cable Hill Partners's 13F filing for Q2 2015, filed 4 Aug 2016.